Journal of Drug Targeting
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q1 | 78.4% | 0.829 | Q1 | 78.5% |
| 2024 | 3.9 | Q1 | 75.4% | 0.870 | Q1 | 80.4% |
| 2023 | 4.3 | Q1 | 81.4% | 0.849 | Q1 | 81.5% |
| 2022 | 4.5 | Q2 | 77.7% | 0.816 | Q1 | 81.1% |
| 2021 | 5.0 | Q2 | 78.7% | 0.793 | Q1 | 80.9% |
| 2020 | — | — | 0.890 | Q1 | 82.5% | |
| 2019 | — | — | 0.748 | Q1 | 78.6% | |
| 2018 | — | — | 0.758 | Q1 | 77.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1061-186X
ISSN
1029-2330
region
Western Europe
coverage
1986-1987, 1992-2026